Compounded Semaglutide
Compounded Semaglutide is a custom-formulated version of the active ingredient in Ozempic® and Wegovy®, used for blood sugar regulation and weight management in adults with type 2 diabetes or clinical obesity.
- The description claims an average weight loss of 15-20% in clinical trials.
- The description claims compounded medications are tailored to patients and made in licensed US facilities.
Variants (1)
- Default Title — 249.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
66%